Imalux Completes Inaugural Service Training Class

Imalux Corporation announced the successful completion of their inaugural service training class. Imalux delivered the hands-on service training at their headquarters in Cleveland, Ohio, for their exclusive Australia and New Zealand distributor – Device Technologies Australia.

The service training is a key accomplishment in the market development activity underway in Australia and New Zealand. This service training comes on the heels of other completed initiatives including image interpretation training for Device Technologies Australia sales and marketing personnel, as well as introduction of the Niris Imaging System at the largest gathering of over 500 professionals in the field of urology in Australasia – the Urological Society of Australasia 2006 Annual Scientific Meeting.

Imalux developed, manufacturers and markets the Niris Imaging System to assist physicians in their diagnosis, treatment, and therapeutic monitoring of diseases in multiple specialties, including urology, gastroenterology, gynecology, dermatology, dentistry, and ENT applications.

Device Technologies Australia has extensive experience in market development and new technology introduction with such companies as STERIS Corporation, Intuitive Surgical, and Boston Scientific. Their strong reputation and established relationships throughout the Australia and New Zealand market will greatly assist in the market acceptance of the Niris Imaging System.

Jerry C Cirino, President and Chief Executive Officer of Imalux states, “the successful completion of our inaugural service training class is a major milestone in our market development efforts. The service training was very well received by the attendees and provided positive feedback on the credibility of the product design and excellent serviceability. This feedback will assist us in our future service training programs.”

About Imalux & the Niris Imaging System

Imalux Corporation, based in Cleveland, Ohio, is commercializing Optical Coherence Tomography (“OCT”) technology originally developed at the Institute of Applied Physics of the Russian Academy of Sciences, one of the main progenitors of OCT technology worldwide. The application of the proven OCT technology is on the verge of becoming the sixth major imaging modality.

The Company’s Niris(TM) Imaging System is a compact, point-of-care System that creates images utilizing harmless, near infrared light. Niris provides clinicians with real-time, high spatial resolution, two-dimensional, cross-sectional depth visualization of normal and abnormal tissue microstructures The spatial resolution of the System is on the order of 0.01 mm, surpassing conventional ultrasound imaging by an order of magnitude.

Imalux OCT technology has been under evaluation with physicians in a number of specialty areas and has been used with more than 3,000 patients worldwide at leading medical institutions including The Cleveland Clinic, The George Washington University Medical Center, Baylor College of Medicine/The Methodist Hospital, University Hospitals of Cleveland, Nizhny Novgorod Medical Academy and Regional Hospital, Nizhny Novgorod, Russia; Municipal Hospital, Chartres, France; State Hospital, Athens, Greece; University Clinic of Eppendorf, Hamburg, Germany; and Hospital Maternidad Nuestra Senora de la Altagracia, Santo Domingo, Dominican Republic.

The Niris Imaging System has received market clearance from the U.S. Food & Drug Administration. In addition, Imalux has been awarded ISO 13485-2003 accreditation and CE mark certification for the Niris Imaging System.